
Clinica Baviera SA
MAD:CBAV

Intrinsic Value
The intrinsic value of one
CBAV
stock under the Base Case scenario is
43.18
EUR.
Compared to the current market price of 39.1 EUR,
Clinica Baviera SA
is
Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Clinica Baviera SA
Fundamental Analysis


Revenue & Expenses Breakdown
Clinica Baviera SA
Balance Sheet Decomposition
Clinica Baviera SA
Current Assets | 63.1m |
Cash & Short-Term Investments | 53.4m |
Receivables | 9.7m |
Non-Current Assets | 167.2m |
Long-Term Investments | 3.4m |
PP&E | 123.7m |
Intangibles | 38.2m |
Other Non-Current Assets | 1.9m |
Free Cash Flow Analysis
Clinica Baviera SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Clinica Baviera SA
Revenue
|
400.3m
EUR
|
Operating Expenses
|
-319.3m
EUR
|
Operating Income
|
81m
EUR
|
Other Expenses
|
-23.3m
EUR
|
Net Income
|
57.7m
EUR
|
CBAV Profitability Score
Profitability Due Diligence
Clinica Baviera SA's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Score
Clinica Baviera SA's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
CBAV Solvency Score
Solvency Due Diligence
Clinica Baviera SA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Score
Clinica Baviera SA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CBAV Price Targets Summary
Clinica Baviera SA
Dividends
Current shareholder yield for CBAV is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CBAV
stock under the Base Case scenario is
43.18
EUR.
Compared to the current market price of 39.1 EUR,
Clinica Baviera SA
is
Undervalued by 9%.